Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Sell
273,120
-4,874,936
-95% -$298M ﹤0.01% 1005
2026
Q1
$357M Sell
5,148,056
-139,736
-3% -$10.8M 0.07% 237
2025
Q4
$402M Sell
5,287,792
-338,824
-6% -$27.2M 0.09% 201
2025
Q3
$485M Sell
5,626,616
-1,224,221
-18% -$92.3M 0.11% 168
2025
Q2
$467M Buy
6,850,837
+916,638
+15% +$56.8M 0.09% 208
2025
Q1
$353M Buy
5,934,199
+570,930
+11% +$36.2M 0.09% 229
2024
Q4
$324M Buy
5,363,269
+1,474
+0% +$90.2K 0.08% 244
2024
Q3
$386M Buy
5,361,795
+5,002,090
+1,391% +$349M 0.1% 184
2024
Q2
$25.3M Sell
359,705
-4,582,135
-93% -$352M 0.01% 788
2024
Q1
$394M Sell
4,941,840
-79,355
-2% -$6.4M 0.14% 144
2023
Q4
$451M Buy
5,021,195
+193,326
+4% +$16.6M 0.18% 116
2023
Q3
$476M Buy
4,827,869
+619,938
+15% +$64.1M 0.21% 93
2023
Q2
$472M Hold
4,207,931
0.23% 91
2023
Q1
$472M Buy
4,207,931
+223,079
+6% +$24.6M 0.23% 91
2022
Q4
$371M Sell
3,984,852
-206,637
-5% -$19.6M 0.19% 113
2022
Q3
$328M Buy
4,191,489
+44,444
+1% +$4.26M 0.18% 116
2022
Q2
$369M Sell
4,147,045
-437,682
-10% -$44.7M 0.19% 106
2022
Q1
$549M Buy
4,584,727
+64,447
+1% +$8.58M 0.24% 84
2021
Q4
$746M Buy
4,520,280
+131,855
+3% +$22M 0.29% 68
2021
Q3
$654M Buy
4,388,425
+472,139
+12% +$73.5M 0.27% 70
2021
Q2
$616M Sell
3,916,286
-157,156
-4% -$23M 0.26% 70
2021
Q1
$562M Sell
4,073,442
-186,925
-4% -$27.2M 0.25% 80
2020
Q4
$555M Buy
4,260,367
+118,860
+3% +$13.2M 0.26% 75
2020
Q3
$380M Sell
4,141,507
-160,798
-4% -$13.5M 0.2% 97
2020
Q2
$335M Buy
4,302,305
+2,242,607
+109% +$154M 0.2% 104
2020
Q1
$101M Buy
2,059,698
+340,551
+20% +$26.7M 0.07% 264
2019
Q4
$163M Buy
1,719,147
+32,094
+2% +$2.94M 0.1% 220
2019
Q3
$147M Sell
1,687,053
-115,419
-6% -$9.64M 0.1% 220
2019
Q2
$146M Sell
1,802,472
-391,733
-18% -$31M 0.1% 217
2019
Q1
$174M Sell
2,194,205
-48,572
-2% -$3.73M 0.13% 174
2018
Q4
$138M Sell
2,242,777
-791,651
-26% -$57.4M 0.12% 192
2018
Q3
$255M Sell
3,034,428
-264,489
-8% -$24.2M 0.19% 109
2018
Q2
$302M Buy
3,298,917
+861,415
+35% +$80.3M 0.23% 85
2018
Q1
$207M Buy
2,437,502
+851,427
+54% +$77.3M 0.16% 133
2017
Q4
$135M Buy
1,586,075
+72,992
+5% +$6.95M 0.11% 200
2017
Q3
$149M Sell
1,513,083
-295,560
-16% -$27.9M 0.14% 162
2017
Q2
$159M Buy
1,808,643
+929
+0.1% +$77.5K 0.15% 151
2017
Q1
$146M Buy
1,807,714
+134,108
+8% +$10.1M 0.15% 154
2016
Q4
$113M Sell
1,673,606
-77,357
-4% -$5.19M 0.13% 183
2016
Q3
$125M Buy
1,750,963
+151,050
+9% +$10.2M 0.13% 168
2016
Q2
$100M Buy
1,599,913
+170,203
+12% +$11.9M 0.11% 200
2016
Q1
$107M Buy
1,429,710
+790,586
+124% +$54.1M 0.12% 177
2015
Q4
$54.8M Sell
639,124
-172,317
-21% -$14.4M 0.06% 329
2015
Q3
$61.7M Sell
811,441
-109,618
-12% -$8.42M 0.07% 309
2015
Q2
$78.4M Sell
921,059
-57,441
-6% -$4.92M 0.08% 286
2015
Q1
$78M Sell
978,500
-19,163
-2% -$1.44M 0.08% 286
2014
Q4
$72.6M Sell
997,663
-16,957
-2% -$1.17M 0.07% 303
2014
Q3
$62.2M Buy
1,014,620
+33,443
+3% +$2.29M 0.06% 337
2014
Q2
$67.4M Sell
981,177
-96,914
-9% -$6.58M 0.07% 309
2014
Q1
$73.2M Buy
1,078,091
+210,047
+24% +$13.4M 0.08% 281
2013
Q4
$52.2M Buy
868,044
+2,794
+0.3% +$162K 0.06% 341
2013
Q3
$50.5M Buy
865,250
+32,653
+4% +$1.81M 0.06% 326
2013
Q2
$42.2M Buy
+832,597
New +$39M 0.05% 359

Other funds holding APTV

UBS AM's APTV Position: Q2 2026 in Review

UBS AM reduced its Aptiv (APTV) stake by 95% in Q2 2026, selling an estimated $298M and leaving 273,120 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

UBS AM first reported a position in APTV in Q2 2013 and has held it in 53 quarters since. The position peaked at $746M in Q4 2021. 657 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • UBS AM held 273,120 shares of Aptiv worth $16.8M as of Q2 2026.
  • UBS AM sold 4,874,936 Aptiv shares in Q2 2026, an estimated $298M.
  • Aptiv made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1005 holding.
  • UBS AM first reported a position in Aptiv in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Aptiv position peaked at $746M in Q4 2021.
  • 657 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.